254
Views
904
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival

, , , , &
Pages 7198-7209 | Received 22 Apr 2003, Accepted 15 Jul 2003, Published online: 27 Mar 2023
 

Abstract

Activation of PERK following the accumulation of unfolded proteins in the endoplasmic reticulum (ER) promotes translation inhibition and cell cycle arrest. PERK function is essential for cell survival following exposure of cells to ER stress, but the mechanisms whereby PERK signaling promotes cell survival are not thoroughly understood. We have identified the Nrf2 transcription factor as a novel PERK substrate. In unstressed cells, Nrf2 is maintained in the cytoplasm via association with Keap1. PERK-dependent phosphorylation triggers dissociation of Nrf2/Keap1 complexes and inhibits reassociation of Nrf2/Keap1 complexes in vitro. Activation of PERK via agents that trigger the unfolded protein response is both necessary and sufficient for dissociation of cytoplasmic Nrf2/Keap1 and subsequent Nrf2 nuclear import. Finally, we demonstrate that cells harboring a targeted deletion of Nrf2 exhibit increased cell death relative to wild-type counterparts following exposure to ER stress. Our data demonstrate that Nrf2 is a critical effector of PERK-mediated cell survival.

ACKNOWLEDGMENTS

We thank Y.W. Kan and J. Chan for providing the Nrf2−/− MEFs and the Nrf2 cDNA; D. Scheuner for the eIF2α(S51A) MEFs; M. Olson for providing the Jac6 and 3F10 monoclonal antibodies; R. Wek for providing anti-PERK antiserum; D. Ron and H. Harding for providing the PERK cDNA and the PERK−/− fibroblasts; C. B. Thompson for providing TNF-α; and M. C. Simon for providing luciferase cDNA.

This work was supported by AHA grant 0060360Z and the Abramson Family Cancer Research Institute (J.A.D.) and grants GM59213 and ES11721 (M.H.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.